Highway Pharmaceuticals is developing oral, liquid, palatable combination therapeutics for human and animal diseases, including:
- “Boosted” cyclosporine (q 7 day) for feline stomatitis (clinical stage)
- “Boosted” sirolimus (q 14 day) for feline chronic kidney disease and hypertrophic cardiomyopathy (clinical stage)
We are moving quickly, both on the development side and regulatory side. Reach out if you want to join us in getting these drugs out to patients and address these critical, unmet health needs.
Who we are
President and founder: Trevor Klee
Patent attorney: Brenda Jarell, PhD, JD, Chair of Life Sciences at Choate
Corporate attorney: Peter Finn, JD, Rubin and Rudman LLC
Pharmacokinetics advisor: Bill Kramer, PhD
Regulatory advisor: Dave Petrick, DVM, JD
Manufacturing partners and clinical partners: Top-notch CDMOs and CROs (details upon request)
Information on this website pertains to pre-clinical or clinical candidates in development and has not been reviewed or approved by the Food and Drug Administration.